Respiratory Diseases Drugs Global Market Report 2021 – COVID-19 Impact And Recovery
The Business Research Company’s Respiratory Diseases Drugs Global Market Report 2021 – COVID-19 Impact And Recovery
LONDON, GREATER LONDON, UK, October 13, 2021 /EINPresswire.com/ — Companies in the respiratory drugs market are offering drugs for customized individual treatment for better treatment against respiratory diseases. Personalized medicine, also referred to as precision medicine, aims to provide medical care according to the patient’s individual characteristics and genetic makeup. Precision therapies are increasingly being adopted in the respiratory drugs market as firms increasingly let go of the one-size-fits-all model for common respiratory conditions. Companies such as GSK, Teva Pharmaceuticals and AstraZeneca have already invested in personalized medicine for respiratory issues such as asthma. For example, PTC Therapeutics is developing a drug which aims to cater to a respiratory mutation which affects about 10% of the population.
Major players covered in the global respiratory diseases drugs industry are GlaxoSmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, Johnson & Johnson.
North America was the largest region in the global respiratory disease drugs market, accounting for 48% of the market in 2020. Western Europe was the second largest region, accounting for 19% of the global respiratory diseases drugs market. Africa was the smallest region in the global respiratory diseases drugs market.
Read More On The Global Respiratory Diseases Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/respiratory-diseases-drugs-global-market-report-2020-30-covid-19-implications-and-growth
The global respiratory diseases drugs market size is expected to decline from $90.32 billion in 2020 to $79.82 billion in 2021 at a compound annual growth rate (CAGR) of -11.6%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $98.81 billion in 2025 at a CAGR of 5%.
TBRC’s global respiratory diseases drugs market report is segmented by type into anti-asthmatics and COPD drugs, cough and cold preparations, by distribution channel into hospital pharmacies, retail pharmacies/ drug stores, others, by route of administration into oral, parenteral, others, by drug classification into branded drugs, generic drugs, by mode of purchase into prescription-based drugs, over-the-counter drugs.
Respiratory Diseases Drugs Global Market Report 2021 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery is one of a series of new reports from The Business Research Company that provides respiratory diseases drugs market overview, forecast respiratory diseases drugs market size and growth for the whole market, respiratory diseases drugs market segments, and geographies, respiratory diseases drugs market trends, respiratory diseases drugs market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Respiratory Diseases Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2143&type=smp
Here Is A List Of Similar Reports By The Business Research Company:
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2021 – By Product (Instruments And Devices, Assays And Reagent), By Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests), By Disease Type (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Diseases), By End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-diagnostic-global-market-report-2020-30-covid-19-growth-and-change
Anesthesia And Respiratory Devices Global Market Report 2021 – By Type (Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables), By End User (Hospitals And Clinics, Diagnostic Laboratories), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), COVID-19 Implications And Growth
https://www.thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-global-market-report
Drugs For Immunotherapy Global Market Report 2021 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases), By End User: Hospitals & Clinics, Ambulatory Surgical Centers), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Or get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/
Oliver Guirdham
The Business Research Company
20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
